How does hcg increase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Human chorionic gonadotropin (hCG) increases primarily during early pregnancy, produced by the placenta after implantation, with levels doubling approximately every 48-72 hours in the first trimester. In non-pregnant individuals, hCG can be increased through exogenous administration via injections or medications, often used in fertility treatments to trigger ovulation or in hormone therapy. Specific hCG levels vary by gestational age, typically reaching 5-50 mIU/mL at 3 weeks and peaking around 100,000-200,000 mIU/mL by 8-11 weeks, before declining to lower levels in later pregnancy.

Key Facts

Overview

Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced primarily during pregnancy by the placenta's syncytiotrophoblast cells after embryo implantation, typically occurring 6-12 days post-fertilization. First discovered in 1927 by Selmar Aschheim and Bernhard Zondek, hCG's role in pregnancy was identified through its presence in urine, leading to early pregnancy tests. Historically, hCG has been used medically since the 1930s, with commercial preparations like Pregnyl introduced in the 1970s. Beyond pregnancy, hCG is produced in small amounts by the pituitary gland in both sexes and can be elevated in certain medical conditions like trophoblastic diseases or testicular tumors. The hormone consists of alpha and beta subunits, with the beta subunit being unique and measured in pregnancy tests. Its discovery revolutionized reproductive medicine, enabling reliable pregnancy detection and advancing fertility treatments.

How It Works

hCG increases through two main mechanisms: endogenous production during pregnancy and exogenous administration. In pregnancy, after the blastocyst implants in the uterine lining (around day 6-12 post-fertilization), placental cells begin secreting hCG, with levels rising exponentially due to rapid placental growth and increased hormone synthesis. This occurs through activation of genes like CGB (chorionic gonadotropin beta) and involves cellular signaling pathways that upregulate production. Exogenously, hCG can be increased via intramuscular or subcutaneous injections of pharmaceutical preparations, such as recombinant hCG (e.g., Ovidrel) or urinary-derived hCG, which mimic the hormone's natural structure. These are absorbed into the bloodstream, binding to luteinizing hormone (LH) receptors in the ovaries or testes. In fertility treatments, a typical dose might be 5,000-10,000 IU to trigger ovulation, with levels peaking 24-36 hours post-injection. The hormone's half-life is approximately 24-36 hours, influencing dosing schedules.

Why It Matters

Understanding hCG increase is crucial for multiple real-world applications. In pregnancy, monitoring hCG levels helps confirm viability, detect ectopic pregnancies, or identify miscarriages, with abnormal patterns signaling potential complications. For fertility treatments, controlled hCG administration is essential for triggering ovulation in assisted reproductive technologies like IVF, improving success rates. Beyond reproduction, hCG is used in hormone therapy for conditions like hypogonadism and in weight loss programs (though controversial). Elevated hCG in non-pregnant individuals can indicate medical issues, such as choriocarcinoma or testicular cancer, aiding early diagnosis. Globally, hCG testing impacts millions annually, with over 100 million pregnancy tests sold yearly, underscoring its significance in healthcare and family planning.

Sources

  1. Human chorionic gonadotropinCC-BY-SA-4.0

Missing an answer?

Suggest a question and we'll generate an answer for it.